Developing drugs against multi-protein complexes is traditionally challenging. In this study, we develop molecular COUPLrs, dual cysteine-reactive small molecules, that can engage complexes across the ...
In vivo CAR T-cell therapy is appealing because it removes many of the cumbersome steps of conventional cellular therapy. Yet, because treatment administers a delivery system and the CAR T-cell ...
1Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2Sino-German Laboratory of Personalized Medicine for Pancreatic ...
Pancreas Center, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, ...
Cancer Discov (2026) 16 (10): OF1.
Cancer Discov (2026) 16 (10): OF1.
Cancer Discov (2026) 16 (10): OF1.
AbstractSingle-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of cancer. However, identifying meaningful disease states from single-cell data remains challenging due to the ...
Copyright held by the owner/author(s).
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Abstract. Advances in cancer prevention, early detection, and treatment have led to substantial improvements in cancer outcomes in the United States over the past several decades. Despite this ...
Summary. Neoadjuvant chemoimmunotherapy improves outcomes in resectable non–small cell lung cancer, yet pathologic response incompletely predicts the durability of benefit. Spatial profiling using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results